Home > Insider Trading > Filing (0000898432-20-000826)

Filing Details

Accession Number:: 0000898432-20-000826
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-23 14:38:15
Reporting Period:: 2020-10-16

Accepted Time:: 2020-10-23 14:38:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1659352	Codiak Biosciences Inc.	CDAK	()	AK

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1582681	Alaska Permanent Fund Corp	801 West 10Th Street Suite 302 Juneau AK 99801		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-16	2,616,093	$0.00	4,512,895	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-16	467,076	$0.00	4,512,895	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-16	747,321	$0.00	4,512,895	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-16	191,721	$0.00	4,512,895	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-16	191,721	$0.00	4,512,895	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2020-10-16	235,000	$15.00	4,512,895	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A redeemable convertible preferred stock	Disposition	2020-10-16	20,450,000	$0.00	2,616,093	$0.00
Common Stock	Series B redeemable convertible preferred stock	Disposition	2020-10-16	3,333,333	$0.00	467,076	$0.00
Common Stock	Series B redeemable convertible preferred stock	Disposition	2020-10-16	5,333,333	$0.00	747,321	$0.00
Common Stock	Series C redeemable convertible preferred stock	Disposition	2020-10-16	1,320,097	$0.00	191,721	$0.00
Common Stock	Series C redeemable convertible preferred stock	Disposition	2020-10-16	1,320,097	$0.00	191,721	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Upon closing of the issuer's initial public offering, the Series A redeemable convertible preferred stock, Series B redeemable convertible preferred stock and Series C redeemable convertible preferred stock converted automatically into Common Stock without payment of further consideration. There was no expiration date for any of the series of preferred stock.
The shares are held by ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in each of ARCH Venture Fund VIII, L.P. and ARCH Venture Fund VIII Overage, L.P..
The Reporting Person disclaims beneficial ownership of the securities, except to the extent of its pecuniary interest therein and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose.
The shares are held by Yukon Investors, LLC. The Reporting Person holds an interest in Yukon Investors, LLC.
The shares are held by ARCH Venture Fund VIII Overage, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII Overage, L.P..
The shares are held by ARCH Venture Fund VIII, L.P.. The Reporting Person holds an indirect interest in ARCH Venture Fund VIII, L.P..
Each share of Series A Preferred Stock converted automatically into Common Stock on a 1-for-7.8170 basis into the aggregate number of shares of Common Stock shown in Column 7 without payment or further consideration upon closing of the issuer's initial public offering on October 16, 2020.
Each share of Series B Preferred Stock converted automatically into Common Stock on a 1-for-7.1366 basis into the aggregate number of shares of Common Stock shown in Column 7 without payment or further consideration upon closing of the issuer's initial public offering on October 16, 2020. The reporting person previously reported shares of common stock into which the Series B Preferred Stock was convertible based on a 1-for-7.1295 conversion ratio estimated at pricing of the Issuer's initial public offering, which reflected a fixed conversion price plus an estimated adjustment based on the issuance of shares in the Issuer's initial public offering.
Each share of Series C Preferred Stock converted automatically into Common Stock on a 1-for-6.8855 basis into the aggregate number of shares of Common Stock shown in Column 7 without payment or further consideration upon closing of the Issuer's initial public offering on October 16, 2020. The reporting person previously reported shares of common stock into which the Series C Preferred Stock was convertible based on a 1-for-6.8758 conversion ratio estimated at pricing of the Issuer's initial public offering, which reflected a fixed conversion price plus an estimated adjustment based on the issuance of shares in the Issuer's initial public offering. price plus an estimated adjustment based on the issuance of shares in the Issuer's initial public offering.